ImmunoCAST

What do thunderstorms, pancake mix, and sweet-and-sour sauce have in common? Each may hold an unexpected clue to an allergic reaction. To prepare for the 2026 ACAAI annual conference, we look back at some of the interesting research from last year's meeting. Drawing from five studies presented at ACAAI 2025, this episode explores unusual allergy presentations and the diagnostic challenges they pose for clinicians. Discover research on thunderstorm-associated asthma exacerbations, oral mite anaphylaxis linked to contaminated flour, IgE-mediated reactions to carmine dye, and a surprising food allergy investigation involving peach and apricot. The discussion also examines emerging evidence connecting peanut-specific IgE and Ara h 2 levels with a history of anaphylaxis. From environmental triggers and hidden allergens to clinical history, specific IgE testing, allergen component diagnostics and interpretation of diagnostic results, these studies offer practical insights to help healthcare providers investigate unexplained allergic reactions and make more informed patient management decisions. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/acaai-2025-allergy-research-clinical-insights.html?cid=0ct_3pc_05032024_9SGOV4

A positive specific IgE result indicates sensitization, but how can clinicians determine whether it explains a patient’s symptoms? Interpreting allergy diagnostic results requires understanding the relationship between clinical history, total IgE, and allergen-specific IgE concentrations, and in this episode, we dive into the best clinical practices for interpreting your patient's specific IgE results. We explore how to evaluate low-level sensitization, distinguish sensitization from clinical allergy, understand why higher specific IgE concentrations do not necessarily predict reaction severity, and recognize cross-reactivity between allergens. It also examines the role of allergen component diagnostics, respiratory allergen profiles, and targeted food allergy diagnostics. Discover practical strategies for interpreting laboratory results in clinical context, identifying potentially relevant allergens, and making more informed diagnostic and referral decisions. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/specific-ige-test-interpretation-podcast-clinical-history.html?cid=0ct_3pc_05032024_9SGOV4

New HEDIS measures are changing the expectations around asthma follow-up, creating an important opportunity for primary care providers to look beyond the exacerbation itself. This episode explores the 2026 HEDIS Follow-Up After Acute and Urgent Care Visits for Asthma (AAF-E) measure and what clinicians should consider assessing during that critical 30-day follow-up. We discuss asthma control, medication adherence and inhaler technique, environmental and allergic triggers, specific IgE testing, and how clinical history plus testing can help determine whether allergic sensitization is relevant. The conversation also examines the relevance of COPD and asthma, including overlapping disease features and upcoming changes to COPD HEDIS measures. Learn how to turn evolving quality measures into a clinically meaningful follow-up that can help clarify what contributed to an exacerbation and inform more targeted long-term patient management. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/asthma-hedis-follow-up-specific-ige-copd.html?cid=0ct_3pc_05032024_9SGOV4

More than 1 in 4 children with food allergy live in food-insecure families, highlighting a challenge that extends well beyond allergen avoidance. This episode explores how food insecurity, socioeconomic status, access to care, insurance coverage, geographic barriers, medication affordability, and access to allergen-free foods can affect food allergy management and quality of life. The conversation covers diagnostic accuracy, unnecessary elimination diets, targeted specific IgE testing, testing with allergen component, nutritional risk, emergency department utilization, pharmacoequity, food insecurity screening, and community resources. Clinicians will learn practical ways to identify barriers affecting their patients, refine food allergy diagnoses, reduce unnecessary food avoidance, and connect families with appropriate nutrition, social, and specialty resources. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/food-allergy-disparities-food-insecurity-primary-care.html?cid=0ct_3pc_05032024_9SGOV4

About 30% to 40% of the world’s population is affected by some form of allergic disease, making allergy a routine consideration in primary care. But as interest in the microbiome grows, clinicians and patients face an important question: what does the evidence actually tell us about its role in allergic disease? This episode explores immune development, the hygiene and biodiversity hypotheses, food allergy, early-life tolerance, the gut-skin axis, atopic dermatitis, asthma, allergic rhinitis, antibiotic exposure, diagnostic testing, and early peanut introduction. The discussion separates established evidence from emerging associations and considers what, if anything, should change in clinical practice today. Clinicians will come away with practical guidance on maintaining evidence-based allergy diagnosis and management while understanding where microbiome research may shape future approaches to prevention and care. Resources and references: https://www.thermofisher.com/phadia/us/en/resources/immunocast/microbiome-and-allergy-what-primary-care-should-know.html?cid=0ct_3pc_05032024_9SGOV4